论文部分内容阅读
经严格设计共37所医院参加研究证明，尿激酶疗法明显优于蛇毒去纤酶，蛇毒去纤酶不适用于急性心肌梗塞治疗。国产尿激酶疗效与国外生产的尿激酶、链激酶相似，且无过敏反应，可推广应用。所探索的尿激酶用药剂量及延迟治疗经验，可提供国内急性心肌梗塞溶栓治疗参考。根据临床?
After a rigorous design of a total of 37 hospitals attending research shows that urokinase therapy was significantly better than snake venom defibrase, snake venom defibrase is not suitable for acute myocardial infarction. Domestic urokinase efficacy and foreign production of urokinase, streptokinase similar, and no allergic reactions, can be extended. Explore the dosage of urokinase and delay treatment experience, can provide domestic reference for thrombolytic therapy of acute myocardial infarction. According to clinical?